Expression and clinical significance of FOXE1 in papillary thyroid carcinoma

Fan,Youben; Ding,Zheng; Yang,Zhili; Deng,Xianzhao; Kang,Jie; Wu,Bo; Zheng,Qi

doi:10.3892/mmr.2013.1494

Expression and clinical significance of FOXE1 in papillary thyroid carcinoma

Authors:
- Youben Fan
- Zheng Ding
- Zhili Yang
- Xianzhao Deng
- Jie Kang
- Bo Wu
- Qi Zheng
View Affiliations

Affiliations: Department of Surgery, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200233, P.R. China, Medical Center of Thyroid Disease, Shanghai Jiaotong University, Shanghai 200233, P.R. China
Published online on: May 28, 2013 https://doi.org/10.3892/mmr.2013.1494
Pages: 123-127

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Papillary thyroid cancer (PTC) is the most common form of well-differentiated thyroid carcinoma. Although the incidence of PTC has been on the increase in China, the precise causes of the disease remain unknown and a prognostic index has yet to be identified. In the present study, quantitative real‑time PCR and western blot analysis were used to detect the mRNA and protein expression levels, respectively, of forkhead box E1 (FOXE1) in 30 PTC tissue specimens matched with adjacent non-tumor thyroid tissues. FOXE1 expression in 81 PTC paraffin-embedded blocks was also evaluated retrospectively by immunohistochemistry (IHC) and its correlation with the clinicopathological parameters of PTC patients was analyzed. Compared with adjacent non-tumor tissues, the mRNA expression levels of the FOXE1 gene in tumor tissues were significantly higher in 65% of PTC tissue specimens. The results from western blotting and IHC analysis were consistent with FOXE1 mRNA expression. Furthermore, the expression of FOXE1 was significantly correlated with the extra-capsular invasion of tumor cells, lymph node metastasis and tumor stage (P=0.048, P=0.036 and P=0.009, respectively). Thus, our results demonstrated that the expression of FOXE1 was significantly increased in PTC tumor tissues and correlated with clinical prognosis. Therefore, FOXE1 is a potential biomarker for PTC prognosis as well as a new therapeutic target.

View Figures

View References

1	Davies L and Welch HG: Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 295:2164–2167. 2006.
2	Hay ID, Thompson GB, Grant CS, et al: Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 26:879–885. 2002.PubMed/NCBI
3	Zannini M, Avantaggiato V, Biffali E, et al: TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J. 16:3185–3197. 1997. View Article : Google Scholar
4	Katoh M and Katoh M: Human FOX gene family (Review). Int J Oncol. 25:1495–1500. 2004.PubMed/NCBI
5	Dathan N, Parlato R, Rosica A, De Felice M and Di Lauro R: Distribution of the titf2/foxe1 gene product is consistent with an important role in the development of foregut endoderm, palate and hair. Dev Dyn. 224:450–456. 2002. View Article : Google Scholar : PubMed/NCBI
6	De Felice M, Ovitt C, Biffali E, et al: A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet. 19:395–398. 1998.PubMed/NCBI
7	Brune K, Hong SM, Li A, et al: Genetic and epigenetic alterations of familial pancreatic cancers. Cancer Epidemiol Biomarkers Prev. 17:3536–3542. 2008. View Article : Google Scholar : PubMed/NCBI
8	Weisenberger DJ, Trinh BN, Campan M, et al: DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res. 36:4689–4698. 2008. View Article : Google Scholar : PubMed/NCBI
9	Venza I, Visalli M, Tripodo B, Lentini M, Teti D and Venza M: Investigation into FOXE1 genetic variations in cutaneous squamous cell carcinoma. Br J Dermatol. 162:681–683. 2010. View Article : Google Scholar : PubMed/NCBI
10	Sequeira MJ, Morgan JM, Fuhrer D, Wheeler MH, Jasani B and Ludgate M: Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid. 11:995–1001. 2001. View Article : Google Scholar : PubMed/NCBI
11	Gudmundsson J, Sulem P, Gudbjartsson DF, et al: Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet. 41:460–464. 2009. View Article : Google Scholar
12	Nam KH, Noh TW, Chung SH, et al: Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinorma. Thyroid. 21:745–750. 2011. View Article : Google Scholar : PubMed/NCBI
13	Shaha AR: TNM classification of thyroid carcinoma. World J Surg. 31:879–887. 2007. View Article : Google Scholar : PubMed/NCBI
14	Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 19:1167–1214. 2009. View Article : Google Scholar : PubMed/NCBI
15	Hannenhalli S and Kaestner KH: The evolution of Fox genes and their role in development and disease. Nat Rev Genet. 10:233–240. 2009. View Article : Google Scholar : PubMed/NCBI
16	Sizemore ST and Keri RA: The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression. J Biol Chem. 287:24631–24640. 2012. View Article : Google Scholar : PubMed/NCBI
17	Nucera C, Eeckhoute J, Finn S, et al: FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res. 15:3680–3689. 2009. View Article : Google Scholar : PubMed/NCBI
18	Bellelli R, Castellone MD, Garcia-Rostan G, et al: FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. Endocr Relat Cancer. 19:695–710. 2012. View Article : Google Scholar : PubMed/NCBI
19	Matsuse M, Takahashi M, Mitsutake N, et al: The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet. 48:645–648. 2011. View Article : Google Scholar : PubMed/NCBI
20	Xu X, Ding H, Rao G, et al: Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr Relat Cancer. 19:167–179. 2012. View Article : Google Scholar : PubMed/NCBI